Literature DB >> 22827470

Thumbs down for HIV: domain level rearrangements do occur in the NNRTI-bound HIV-1 reverse transcriptase.

David W Wright1, S Kashif Sadiq, Gianni De Fabritiis, Peter V Coveney.   

Abstract

One of the principal targets in human immunodeficiency virus type 1 (HIV-1) therapy is the reverse transcriptase (RT) enzyme. Non-nucleoside RT inhibitors (NNRTIs) are a class of highly specific drugs which bind to a pocket approximately 10 Å from the polymerase active site, inhibiting the enzyme allosterically. It is widely believed that NNRTIs function as "molecular wedges", disrupting the region between thumb and palm subdomains of the p66 subunit and locking the thumb in a wide-open conformation. Crystal structure data suggest that the binding of NNRTIs forces RT into a wide-open conformation in which the separation between the thumb and fingers subdomains is much higher than in the apo structure. Using ensemble molecular dynamics simulations (aggregate sampling ∼600 ns), we have captured RT bound to the NNRTI efavirenz in a closed conformation similar to that of the apo enzyme, suggesting the constraint of thumb motion is not as complete as previously believed. Rather, our investigation confirms that a conformational distribution across open and closed states must exist in the drug-bound enzyme and that allosteric modulation is effected via the alteration of the kinetic landscape of conformational transitions upon drug-binding. A more detailed understanding of the mechanism of NNRTI inhibition and the effect of binding upon domain motion could aid the design of more effective inhibitors and help identify novel allosteric sites.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22827470     DOI: 10.1021/ja301565k

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  9 in total

1.  Protein-mediated antagonism between HIV reverse transcriptase ligands nevirapine and MgATP.

Authors:  Xunhai Zheng; Geoffrey A Mueller; Eugene F DeRose; Robert E London
Journal:  Biophys J       Date:  2013-06-18       Impact factor: 4.033

2.  Molecular dynamics study of HIV-1 RT-DNA-nevirapine complexes explains NNRTI inhibition and resistance by connection mutations.

Authors:  R S K Vijayan; Eddy Arnold; Kalyan Das
Journal:  Proteins       Date:  2013-11-22

3.  Effects of the protonation state in the interaction of an HIV-1 reverse transcriptase (RT) amino acid, Lys101, and a non nucleoside RT inhibitor, GW420867X.

Authors:  Sérgio E Galembeck; F Matthias Bickelhaupt; Célia Fonseca Guerra; Eduardo Galembeck
Journal:  J Mol Model       Date:  2014-06-26       Impact factor: 1.810

4.  Non-nucleoside Reverse Transcriptase Inhibitors Inhibit Reverse Transcriptase through a Mutually Exclusive Interaction with Divalent Cation-dNTP Complexes.

Authors:  Jeffrey J DeStefano
Journal:  Biochemistry       Date:  2019-04-05       Impact factor: 3.321

5.  NMR characterization of HIV-1 reverse transcriptase binding to various non-nucleoside reverse transcriptase inhibitors with different activities.

Authors:  Ratsupa Thammaporn; Maho Yagi-Utsumi; Takumi Yamaguchi; Pornthip Boonsri; Patchreenart Saparpakorn; Kiattawee Choowongkomon; Supanna Techasakul; Koichi Kato; Supa Hannongbua
Journal:  Sci Rep       Date:  2015-10-29       Impact factor: 4.379

Review 6.  Large Multidomain Protein NMR: HIV-1 Reverse Transcriptase Precursor in Solution.

Authors:  Tatiana V Ilina; Zhaoyong Xi; Teresa Brosenitsch; Nicolas Sluis-Cremer; Rieko Ishima
Journal:  Int J Mol Sci       Date:  2020-12-15       Impact factor: 5.923

7.  Computational study on the inhibitor binding mode and allosteric regulation mechanism in hepatitis C virus NS3/4A protein.

Authors:  Weiwei Xue; Ying Yang; Xiaoting Wang; Huanxiang Liu; Xiaojun Yao
Journal:  PLoS One       Date:  2014-02-25       Impact factor: 3.240

8.  Biophysical Insights into the Inhibitory Mechanism of Non-Nucleoside HIV-1 Reverse Transcriptase Inhibitors.

Authors:  Grant Schauer; Sanford Leuba; Nicolas Sluis-Cremer
Journal:  Biomolecules       Date:  2013-11-01

Review 9.  Non-Nucleoside Reverse Transcriptase Inhibitors Join Forces with Integrase Inhibitors to Combat HIV.

Authors:  Daniel M Himmel; Eddy Arnold
Journal:  Pharmaceuticals (Basel)       Date:  2020-06-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.